Preclinical target validation using patient-derived cells.
Edwards AM., Arrowsmith CH., Bountra C., Bunnage ME., Feldmann M., Knight JC., Patel DD., Prinos P., Taylor MD., Sundström M., SGC Open Source Target-Discovery Partnership .
The Structural Genomics Consortium (SGC) and its clinical, industry and disease-foundation partners are launching open-source preclinical translational medicine studies.